Neuberger Berman Group LLC grew its position in Molina Healthcare, Inc. (NYSE:MOH) by 23.0% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 533,021 shares of the company’s stock after purchasing an additional 99,543 shares during the period. Neuberger Berman Group LLC owned about 0.93% of Molina Healthcare worth $36,651,000 at the end of the most recent quarter.

Other hedge funds have also recently modified their holdings of the company. Zions Bancorporation acquired a new position in shares of Molina Healthcare during the 3rd quarter valued at about $118,000. Tiedemann Wealth Management LLC increased its holdings in shares of Molina Healthcare by 7.8% during the 3rd quarter. Tiedemann Wealth Management LLC now owns 1,440,066 shares of the company’s stock valued at $135,000 after acquiring an additional 103,775 shares during the last quarter. Riverhead Capital Management LLC increased its holdings in shares of Molina Healthcare by 64.2% during the 2nd quarter. Riverhead Capital Management LLC now owns 2,463 shares of the company’s stock valued at $170,000 after acquiring an additional 963 shares during the last quarter. Sabal Trust CO acquired a new position in shares of Molina Healthcare during the 3rd quarter valued at about $206,000. Finally, Bronfman E.L. Rothschild L.P. increased its holdings in shares of Molina Healthcare by 478.7% during the 2nd quarter. Bronfman E.L. Rothschild L.P. now owns 3,316 shares of the company’s stock valued at $229,000 after acquiring an additional 2,743 shares during the last quarter. 96.23% of the stock is currently owned by institutional investors.

Shares of Molina Healthcare, Inc. (NYSE MOH) opened at $78.40 on Thursday. Molina Healthcare, Inc. has a twelve month low of $42.56 and a twelve month high of $80.74. The firm has a market capitalization of $4,368.26, a price-to-earnings ratio of 23.76 and a beta of 0.97. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 1.06.

Molina Healthcare (NYSE:MOH) last released its earnings results on Thursday, November 2nd. The company reported ($1.62) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.23 by ($1.85). The firm had revenue of $5.03 billion during the quarter, compared to analyst estimates of $4.95 billion. Molina Healthcare had a negative net margin of 1.76% and a positive return on equity of 17.76%. The firm’s quarterly revenue was up 10.7% on a year-over-year basis. During the same period last year, the business posted $0.85 earnings per share. equities analysts anticipate that Molina Healthcare, Inc. will post -3.88 earnings per share for the current fiscal year.

A number of analysts have issued reports on the company. Jefferies Group raised their target price on Molina Healthcare from $60.00 to $64.00 and gave the company a “hold” rating in a report on Friday, October 13th. Wolfe Research raised Molina Healthcare from a “market perform” rating to an “outperform” rating in a report on Monday, October 23rd. Morgan Stanley raised their target price on Molina Healthcare from $68.00 to $89.00 and gave the company an “overweight” rating in a report on Friday, November 3rd. Zacks Investment Research raised Molina Healthcare from a “sell” rating to a “hold” rating in a report on Monday, November 6th. Finally, Raymond James Financial reiterated a “hold” rating on shares of Molina Healthcare in a research report on Friday, December 8th. Three analysts have rated the stock with a sell rating, eleven have given a hold rating and four have given a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus price target of $64.25.

In related news, Director John C. Molina sold 19,885 shares of Molina Healthcare stock in a transaction on Monday, December 18th. The stock was sold at an average price of $75.47, for a total transaction of $1,500,720.95. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Garrey Carruthers sold 1,300 shares of Molina Healthcare stock in a transaction on Thursday, November 16th. The stock was sold at an average price of $75.66, for a total value of $98,358.00. Following the sale, the director now directly owns 7,016 shares of the company’s stock, valued at $530,830.56. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 727,953 shares of company stock valued at $52,635,892. 6.20% of the stock is owned by insiders.

ILLEGAL ACTIVITY NOTICE: This report was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this report on another website, it was illegally stolen and republished in violation of U.S. & international copyright law. The correct version of this report can be read at https://www.thecerbatgem.com/2017/12/21/neuberger-berman-group-llc-raises-holdings-in-molina-healthcare-inc-moh.html.

Molina Healthcare Profile

Molina Healthcare, Inc offers Medicaid-related solutions for low-income families and individuals, and assists government agencies in their administration of the Medicaid program. The Company operates through three segments: Health Plans, Molina Medicaid Solutions and Other, which includes its Pathways Health and Community Support LLC (Pathways) business.

Want to see what other hedge funds are holding MOH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Molina Healthcare, Inc. (NYSE:MOH).

Institutional Ownership by Quarter for Molina Healthcare (NYSE:MOH)

Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.